BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35430149)

  • 1. Noninvasive monitoring of allograft rejection in a rat lung transplant model: Application of machine learning-based
    Tian D; Shiiya H; Takahashi M; Terasaki Y; Urushiyama H; Shinozaki-Ushiku A; Yan HJ; Sato M; Nakajima J
    J Heart Lung Transplant; 2022 Jun; 41(6):722-731. PubMed ID: 35430149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An [
    Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
    Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of radiomics based on
    Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prediction of regional lymph node metastasis of colorectal cancer based on
    He J; Wang Q; Zhang Y; Wu H; Zhou Y; Zhao S
    Ann Nucl Med; 2021 May; 35(5):617-627. PubMed ID: 33738763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using
    Jiang X; Li T; Wang J; Zhang Z; Chen X; Zhang J; Zhao X
    Cancer Biother Radiopharm; 2024 Apr; 39(3):169-177. PubMed ID: 38193811
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT radiomics analysis of lung cancers: Differentiation of squamous cell carcinoma from adenocarcinoma, a correlative study with FDG uptake.
    Tomori Y; Yamashiro T; Tomita H; Tsubakimoto M; Ishigami K; Atsumi E; Murayama S
    Eur J Radiol; 2020 Jul; 128():109032. PubMed ID: 32361604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts.
    Grahovac M; Spielvogel CP; Krajnc D; Ecsedi B; Traub-Weidinger T; Rasul S; Kluge K; Zhao M; Li X; Hacker M; Haug A; Papp L
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1607-1620. PubMed ID: 36738311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtype classification of breast cancer using established radiomic signature models based on
    Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
    Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-treatment
    Ahn HK; Lee H; Kim SG; Hyun SH
    Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum Standardized Uptake Value of
    Niu R; Gao J; Shao X; Wang J; Jiang Z; Shi Y; Zhang F; Wang Y; Shao X
    Front Oncol; 2021; 11():727094. PubMed ID: 34976790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics based on
    Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
    Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Noortman WA; Vriens D; de Geus-Oei LF; Slump CH; Aarntzen EH; van Berkel A; Timmers HJLM; van Velden FHP
    Eur Radiol; 2022 Oct; 32(10):7227-7236. PubMed ID: 36001126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning for differentiating lung squamous cell cancer from adenocarcinoma using Clinical-Metabolic characteristics and 18F-FDG PET/CT radiomics.
    Zhang Y; Liu H; Chang C; Yin Y; Wang R
    PLoS One; 2024; 19(4):e0300170. PubMed ID: 38568892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of
    Nakajo M; Jinguji M; Ito S; Tani A; Hirahara M; Yoshiura T
    Jpn J Radiol; 2024 Jan; 42(1):28-55. PubMed ID: 37526865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of 18 F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy.
    Park SB; Kim KU; Park YW; Hwang JH; Lim CH
    Nucl Med Commun; 2023 Feb; 44(2):161-168. PubMed ID: 36458424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
    Ruan D; Fang J; Teng X
    Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):70-83. PubMed ID: 35420272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning in the differentiation of follicular lymphoma from diffuse large B-cell lymphoma with radiomic [
    de Jesus FM; Yin Y; Mantzorou-Kyriaki E; Kahle XU; de Haas RJ; Yakar D; Glaudemans AWJM; Noordzij W; Kwee TC; Nijland M
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1535-1543. PubMed ID: 34850248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts Tumor Immune Profiles in Non-Small Cell Lung Cancer: A Retrospective Multicohort Study.
    Tong H; Sun J; Fang J; Zhang M; Liu H; Xia R; Zhou W; Liu K; Chen X
    Front Immunol; 2022; 13():859323. PubMed ID: 35572597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.